@article{006dfcb585334a69b95aa1c25b80d0e2,
title = "Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial",
abstract = "N/A",
keywords = "Antineoplastic Combined Chemotherapy Protocols, Colonic Neoplasms, Colorectal Neoplasms, Humans, Ipilimumab, Microsatellite Repeats, Nivolumab, O(6)-Methylguanine-DNA Methyltransferase, Rectal Neoplasms, Temozolomide, Antineoplastic Combined Chemotherapy Protocols, Colonic Neoplasms, Colorectal Neoplasms, Humans, Ipilimumab, Microsatellite Repeats, Nivolumab, O(6)-Methylguanine-DNA Methyltransferase, Rectal Neoplasms, Temozolomide",
author = "Federica Morano and Alessandra Raimondi and Filippo Pagani and Sara Lonardi and Lisa Salvatore and Chiara Cremolini and Sabina Murgioni and Giovanni Randon and Federica Palermo and Lorenzo Antonuzzo and Nicoletta Pella and Patrizia Racca and Michele Prisciandaro and Monica Niger and Francesca Corti and Francesca Bergamo and Alberto Zaniboni and Margherita Ratti and Michele Palazzo and Celeste Cagnazzo and Calegari, {Maria Alessandra} and Federica Marmorino and Iolanda Capone and Elena Conca and Adele Busico and Silvia Brich and Elena Tamborini and Federica Perrone and {Di Maio}, Massimo and Massimo Milione and {Di Bartolomeo}, Maria and {De Braud}, Filippo and Filippo Pietrantonio",
year = "2022",
doi = "10.1200/JCO.21.02583",
language = "English",
volume = "40",
pages = "1562--1573",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "Lippincott Williams and Wilkins",
}
